PET-based imaging study designed to assess the biodistribution of CIT-013 and associate disease activity with CIT-013 target disposition in participants…
Leiden, the Netherlands, February 17, 2026: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) today announced its participation…
The data virtualization cloud market is expanding rapidly as enterprises adopt real-time, secure data integration across hybrid and multi-cloud environments,…
New index-based pricing model aims to offer governments worldwide equitable access to world class technology, software independence Colombo, Sri Lanka,…